Lifecore Biomedical, Inc.
LFCR
$7.61
$0.395.40%
NASDAQ
| 05/25/2025 | 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.72M | -44.65M | -14.25M | 6.54M | 12.01M |
| Total Depreciation and Amortization | 8.03M | 8.13M | 8.06M | 7.78M | 7.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.18M | 38.91M | 8.26M | -14.34M | -16.01M |
| Change in Net Operating Assets | -4.70M | 775.00K | -1.52M | 7.97M | -3.70M |
| Cash from Operations | -206.00K | 3.16M | 545.00K | 7.94M | 257.00K |
| Capital Expenditure | -13.42M | -14.03M | -14.94M | -16.73M | -18.40M |
| Sale of Property, Plant, and Equipment | 7.00M | 7.00M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.42M | -7.03M | -14.94M | -16.73M | -18.40M |
| Total Debt Issued | 128.57M | 146.48M | 149.52M | 149.22M | 149.59M |
| Total Debt Repaid | -146.69M | -164.83M | -158.83M | -147.63M | -147.42M |
| Issuance of Common Stock | 23.86M | 23.86M | 23.84M | 1.00K | 724.00K |
| Repurchase of Common Stock | -1.28M | -1.16M | -1.07M | -696.00K | -152.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.97M | 1.86M | 7.17M | 4.77M | 4.77M |
| Cash from Financing | 6.42M | 6.21M | 20.63M | 5.67M | 7.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -197.00K | 2.34M | 6.23M | -3.12M | -10.63M |